Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

Clinical Site, Rogers

Clinical Site, Cerritos

Clinical Site, Costa Mesa

Clinical Site, Culver City

Clinical Site, Garden Grove

Clinical Site, Glendale

Clinical Site, Lemon Grove

Clinical Site, Oceanside

Clinical Site, Pico Rivera

Clinical Site, Riverside

Clinical Site, San Diego

Clinical Site, Santa Rosa

Clinical Site, Sherman Oaks

Clinical Site, Temecula

Clinical Site, Jacksonville

Clinical Site, Lauderhill

Clinical Site, Miami

Clinical Site, Orange City

Clinical Site, Orlando

Clinical Site, Atlanta

Clinical Site, Savannah

Clinical Site, Chicago

Clinical Site, Lake Charles

Clinical Site, Baltimore

Clinical Site, O'Fallon

Clinical Site, St Louis

Clinical Site, Las Vegas

Clinical Site, Berlin

Clinical Site, Cherry Hill

Clinical Site, Toms River

Clinical Site, Cedarhurst

Clinical Site, New York

Clinical Site, Rochester

Clinical Site, Staten Island

Clinical Site, Charlotte

Clinical Site, Cincinnati

Clinical Site, Dayton

Clinical Site, Garfield Heights

Clinical Site, Allentown

Clinical Site, Philadelphia

Clinical Site, The Woodlands

Clinical Site, Everett

Clinical Site, Burgas

Clinical Site, Kardzhali

Clinical Site, Lovech

Clinical Site, Pleven

Clinical Site, Plovdiv

Clinical Site, Rousse

Clinical Site, Sofia

Clinical Site, Varna

Clinical Site, Veliko Tarnovo

Clinical Site, Vratsa

Clinical Site, Moscow

Clinical Site, Nizhny Novgorod

Clinical Site, Omsk

Clinical Site, Saint Petersburg

Clinical Site, Samara

Clinical Site, Saratov

Clinical Site, Tomsk

Clinical Site, Belgrade

Clinical Site, Kovin

Clinical Site, Novi Sad

Clinical Site, Šumadija

Clinical Site, Ivano-Frankivsk

Clinical Site, Kharkiv

Clinical Site, Kropyvnytskyi

Clinical Site, Odesa

Clinical Site, Poltava

Clinical Site, Smila

Clinical Site, Vasylkiv

Clinical Site, Vinnytsia